SCHEMBL1012824

SCHEMBL1012824

CCC(Nc1cc(OC)cc(OC)c1)S(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 2/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4614536 0.80 LMNA (0.34) KMT2ASMN1; SMN2LMNAHTTKDM4E
SCHEMBL1823997 0.78 HTT (0.46) POLBLMNAHTTCYP1A2CYP3A4
SCHEMBL8440991 0.75 TDP1 (0.35) KMT2ALMNAHTTMEN1
SCHEMBL3274606 0.75 KMT2A (0.47) KMT2APOLBSMN1; SMN2LMNAHTT
SCHEMBL8435611 0.74 ACP1 (0.36) KMT2ATSHRMEN1ALDH1A1CYP3A4
SCHEMBL8439787 0.74 MEP1B (0.38) KMT2APOLBSMN1; SMN2HTTTSHR
SCHEMBL1009042 0.73 TDP1 (0.42) KMT2ASMN1; SMN2LMNATSHRTP53
SCHEMBL21359770 0.72 KMT2A (0.41) KMT2APOLBSMN1; SMN2LMNATSHR
Hydrochloric Acid SCHEMBL29143533 0.71 MEN1 (0.46) KMT2APOLBSMN1; SMN2LMNATSHR
SCHEMBL27450701 0.70 KMT2A (0.41) KMT2APOLBSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12264356-B2 Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor NIHON UNIVERSITY (JP) 2025-04-01 US disclosed
WO-2023191077-A1 METHOD FOR ASSISTING WITH STRATIFICATION OF FRAILTY PROGRESSION LEVEL EVALUATION, STRATIFICATION DEVICE, AND STRATIFICATION PROGRAM 東洋紡株式会社 2023-10-05 WO disclosed
WO-2023190087-A1 ENHACEMENT OF ACCURACY WHEN MEASURING HIGH-CREATININE-VALUE SPECIMEN 東洋紡株式会社 2023-10-05 WO disclosed
WO-2023085323-A1 METHOD FOR REDUCING MEASUREMENT ERRORS DUE TO HEMOLYZED HEMOGLOBIN 東洋紡株式会社 2023-05-19 WO disclosed
US-20200347458-A1 METHOD FOR DETERMINING SENSITIVITY TO SGLT2 INHIBITOR AND SENSITIVITY MARKER FOR SGLT2 INHIBITOR NIHON UNIVERSITY (JP) 2020-11-05 US disclosed
WO-2019216407-A1 METHOD FOR SUPPRESSING DECREASE IN SENSITIVITY OF REAGENT KIT FOR MEASURING BIOLOGICAL COMPONENT 東洋紡株式会社 (JP) 2019-11-14 WO disclosed
WO-2019216406-A1 METHOD FOR SUPPRESSING REDUCTIONS IN BIOLOGICAL COMPONENT MEASUREMENT REAGENT KIT SENSITIVITY 東洋紡株式会社 (JP) 2019-11-14 WO disclosed
WO-2019216408-A1 METHOD FOR SUPPRESSING REDUCTIONS IN BIOLOGICAL COMPONENT MEASUREMENT REAGENT KIT SENSITIVITY 東洋紡株式会社 (JP) 2019-11-14 WO disclosed
WO-2019216405-A1 METHOD FOR SUPPRESSING REDUCTION IN SENSITIVITY OF BIOLOGICAL-COMPONENT-MEASURING REAGENT KIT 東洋紡株式会社 (JP) 2019-11-14 WO disclosed
EP-2495332-B1 METHOD FOR MEASURING CHOLESTEROL IN ApoE-CONTAINING HDL DENKA SEIKEN KK (JP) 2018-07-25 EP disclosed
EP-0764848-A1 METHOD OF QUANTIFYING CHOLESTEROL IN LOW-DENSITY OR VERY-LOW-DENSITY LIPOPROTEIN KYOWA MEDEX CO., LTD. (JP) 1997-03-26 EP disclosed
EP-0763741-A1 METHOD OF QUANTITATING CHOLESTEROL IN LOW-DENSITY LIPOPROTEIN KYOWA MEDEX CO., LTD. (JP) 1997-03-19 EP disclosed
EP-0727495-A2 Quantitation of inorganic phosphate and trehalose KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1996-08-21 EP disclosed
EP-0699767-A1 METHOD OF DETERMINING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN KYOWA MEDEX CO., LTD. (JP) 1996-03-06 EP disclosed
EP-0353311-B1 NUCLEOSIDE OXIDASE AND ANALYTICAL METHOD USING SAME OTSUKA FOOD CO LTD (JP) 1995-01-18 EP disclosed
US-5156955-A Used as enzyme for catalyzing oxidation reaction of nucleoside OTSUKA FOODS CO., LTD. (JP) 1992-10-20 US disclosed
EP-0353311-A1 NUCLEOSIDE OXIDASE AND ANALYTICAL METHOD USING SAME OTSUKA FOODS CO., LTD. (JP) 1990-02-07 EP disclosed
EP-0267247-A1 PROCESS AND REAGENT FOR DETECTING HEART LESIONS OR DISEASES Roche Diagnostics GmbH (DE) 1988-05-18 EP disclosed
WO-1987006619-A1 PROCESS AND REAGENT FOR DETECTING HEART LESIONS OR DISEASES BOEHRINGER MANNHEIM GMBH (DE) 1987-11-05 WO disclosed
EP-0243901-A1 Process and reagent for the detection of heart lesions or heart diseases Roche Diagnostics GmbH (DE) 1987-11-04 EP disclosed